DR-03 MECHANISMS THAT CAUSE RESISTANCE TO EGFR TARGETED THERAPIES IN GLIOMA

Por Johns, Terrance
Publicado em 2014

EXTH-08. DISCOVERY OF CT-179: A SMALL MOLECULE INHIBITOR OF THE OLIG2 TRANSCRIPTION FACTOR WITH POTENT ANTI-TUMOUR ACTIVITY IN HIGH-GRADE GLIOMA

Por Johns, Terrance
Publicado no Neuro Oncol (2017)

CADD-17. CT-179: AN INHIBITOR OF THE OLIG2 TRANSCRIPTION FACTOR WITH POTENT ANTI-TUMOUR ACTIVITY IN BRAIN CANCER

Por Johns, Terrance
Publicado no Neuro Oncol (2018)

ATPS-27 SIMULTANEOUS TARGETING OF THE CELL CYCLE AND GLOBAL TRANSCRIPTION BY IRREVERSIBLE INHIBITION OF CDK7 AS A NOVEL THERAPEUTIC APPROACH FOR HIGH-GRADE GLIOMA

Por Greenall, Sameer, Johns, Terrance
Publicado no Neuro Oncol (2015)

EGFRvIII: the promiscuous mutation

Por Greenall, Sameer A, Johns, Terrance G
Publicado no Cell Death Discov (2016)

A Simple Guide Screw Method for Intracranial Xenograft Studies in Mice

Por Donoghue, Jacqueline F., Bogler, Oliver, Johns, Terrance G.
Publicado em 2011

CSIG-07 EGFRvIII MEDIATED TRANSACTIVATION OF RECEPTOR TYROSINE KINASES IN GLIOMA: MECHANISM AND THERAPEUTIC IMPLICATIONS

Por Johns, Terrance, Greenall, Sam, Donoghue, Jacqui, Adams, Tim
Publicado no Neuro Oncol (2015)

EAPH-16. DISCOVERY OF CT-179: A SMALL MOLECULE INHIBITOR OF THE OLIG2 TRANSCRIPTION FACTOR WITH POTENT ANTI-TUMOR IN PEDIATRIC BRAIN CANCER

Por Johns, Terrance, Greenall, Sameer, Chen, Charlotte, Day, Bryan
Publicado no Neuro Oncol (2018)

Incomplete target neutralization by the anti-cancer antibody rilotumumab

Por Greenall, Sameer A., Adams, Timothy E., Johns, Terrance G.
Publicado no MAbs (2016)

Axitinib Has Antiangiogenic and Antitumorigenic Activity in Myxoid Liposarcoma

Por Kerr, Lauren T., Donoghue, Jacqueline F., Wilding, Alexander L., Johns, Terrance G.
Publicado no Sarcoma (2016)

Differential Sensitivity of Human Hepatocellular Carcinoma Xenografts to an IGF-II Neutralizing Antibody May Involve Activated STAT3

Por Greenall, Sameer A., Donoghue, Jacqueline, Johns, Terrance G., Adams, Timothy E.
Publicado no Transl Oncol (2018)

DDIS-19. CT-179: AN INHIBITOR OF THE OLIG2 TRANSCRIPTION FACTOR WITH POTENT ANTI-TUMOUR ACTIVITY IN BRAIN CANCER

Por Johns, Terrance, Greenall, Sameer, Chen, Shengnan, Stewart, Rodney, Alton, Gordon, Kesari, Santosh
Publicado no Neuro Oncol (2018)

A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain Tumors

Por Endersby, Raelene, Whitehouse, Jacqueline, Hii, Hilary, Greenall, Sameer A., Johns, Terrance G., Gottardo, Nicholas G.
Publicado no Neoplasia (2018)

Targeting a unique EGFR epitope with monoclonal antibody 806 activates NF-κB and initiates tumour vascular normalization

Por Gan, Hui K, Lappas, Martha, Cao, Diana X, Cvrljevdic, Anna, Scott, Andrew M, Johns, Terrance G
Publicado no J Cell Mol Med (2009)

Heparin-binding EGF-like Growth Factor Signaling in Flow-induced Arterial Remodeling

Por Zhang, Hua, Sunnarborg, Susan W, McNaughton, K Kirk, Johns, Terrance G, Lee, David C, Faber, James E
Publicado em 2008

Combination of palbociclib and radiotherapy for glioblastoma

Por Whittaker, Shane, Madani, Daniel, Joshi, Swapna, Chung, Sylvia A, Johns, Terrance, Day, Bryan, Khasraw, Mustafa, McDonald, Kerrie L
Publicado no Cell Death Discov (2017)

The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis

Por Clements, Craig S., Reid, Hugh H., Beddoe, Travis, Tynan, Fleur E., Perugini, Matthew A., Johns, Terrance G., Bernard, Claude C. A., Rossjohn, Jamie
Publicado em 2003

The Plasticity of Oncogene Addiction: Implications for Targeted Therapies Directed to Receptor Tyrosine Kinases

Por Pillay, Vinochani, Allaf, Layal, Wilding, Alexander L, Donoghue, Jacqui F, Court, Naomi W, Greenall, Steve A, Scott, Andrew M, Johns, Terrance G
Publicado em 2009

Development and Biological Evaluation of a Photoactivatable Small Molecule Microtubule-Targeting Agent

Por Döbber, Alexander, Phoa, Athena F., Abbassi, Ramzi H., Stringer, Brett W., Day, Bryan W., Johns, Terrance G., Abadleh, Mohammed, Peifer, Christian, Munoz, Lenka
Publicado no ACS Med Chem Lett (2017)

Internalization, Intracellular Trafficking, and Biodistribution of Monoclonal Antibody 806: A Novel Anti-Epidermal Growth Factor Receptor Antibody

Por Perera, Rushika M, Zoncu, Roberto, Johns, Terrance G, Pypaert, Marc, Lee, Fook-Thean, Mellman, Ira, Old, Lloyd J, Toomre, Derek K, Scott, Andrew M
Publicado em 2007